Can Magnesium Help With Eye Twitching? What the Science Says

Can Magnesium Help With Eye Twitching? What the Science Says

Three days now, that eyelid has been flickering. Not painful — just maddeningly persistent, the kind of tiny involuntary spasm that makes you suddenly aware of a muscle you never think about. Someone on Reddit mentioned magnesium. Your coworker swears by it. The supplement aisle, naturally, has a dozen options. Before you swallow anything, though, there is an actual body of research on this question — and the answer is more nuanced than most wellness blogs let on.

What’s actually twitching

That annoying flicker has a medical name: eyelid myokymia. It’s a fine, involuntary contraction of the orbicularis oculi, the ring-shaped muscle around your eye. Almost always benign and self-limiting, it resolves on its own within days or weeks. StatPearls notes the condition is distinct from blepharospasm — a more severe form of involuntary eyelid closure that can actually interfere with vision. Myokymia by itself is just a nuisance; it does not progress to anything dangerous.

Still, the magnesium hypothesis is biologically plausible. Magnesium acts as a natural calcium-channel blocker at the neuromuscular junction, regulating how easily nerves fire and muscles contract. When serum magnesium runs low, neurons can get hyperexcitable. In severe deficiency, visible muscle fasciculations, cramps, and even tetany can appear. A 2023 review in Neurology Clinical Practice documented a range of movement disorders tied to hypomagnesemia — from generalized tremors to chorea. The reasoning goes: if low magnesium can make muscles twitch systemically, maybe it also explains an isolated eyelid flicker.

Yet the evidence for that specific leap is surprisingly thin.

What the cross-sectional studies actually found

Three decent-sized studies published since 2020 have looked squarely at this question: do people with eyelid twitching have lower serum magnesium than people who don’t? None of them found a meaningful difference.

Consider the 2021 Korean study in the Korean Journal of Health Promotion. Kim and colleagues compared 269 patients with eyelid myokymia against matched controls. The myokymia group averaged 2.14 mg/dL of serum magnesium. Controls came in at 2.18 mg/dL. That difference was not statistically significant (p=0.110), and both values sat comfortably within the normal reference range. The researchers’ conclusion was blunt: “These data suggested that the eyelid myokymia is not related to the serum magnesium level as well as calcium and phosphate. Only fatigue and sleep quality were shown the relationship with eyelid myokymia.”

A 2024 cross-sectional study by Gunes, published in Cureus, examined 206 participants and reached a nearly identical conclusion. “Prolonged digital screen time might play a role in the development of EM,” the authors wrote. “On the other hand, no relationship was found between eyelid twitching and blood electrolyte levels.” Screen time told a different story. In the myokymia group, daily screen time averaged 6.88 hours. Among controls, it was 4.84 hours — a highly significant gap (p<0.001).

Then there’s the blepharospasm angle. In a 2020 paper in Graefe’s Archive, Serefoglu Cabuk and colleagues examined serum minerals in 72 patients with benign essential blepharospasm (BEB) — that more severe, sustained eyelid-closure condition. Serum magnesium was indistinguishable from controls. They did report a statistically significant difference in serum calcium (9.5 vs. 9.9 mg/dL, p=0.002), but both values fell within the normal clinical range, making the biological relevance uncertain.

Take these together and the cross-sectional literature makes a consistent case: if you walk into a clinic with an eyelid twitch, your blood magnesium level will probably look the same as anyone else’s. The mineral simply does not appear to be the differentiator.

The positive studies: what they say and what they don’t

The picture isn’t entirely one-sided. Two small randomized controlled trials — both from an earlier era, both focused on blepharospasm rather than ordinary eyelid myokymia — reported benefit from oral magnesium.

A 1997 trial by Garrity and colleagues, published in Ophthalmic Plastic and Reconstructive Surgery, randomized 36 patients with blepharospasm to receive 200 mg per day of magnesium aspartate or placebo over four weeks. The magnesium group showed measurable improvement in spasm frequency. A second trial by Sharma (2011) also reported positive results with magnesium for blepharospasm, though the study’s size and methodology are harder to verify in the publicly available literature.

These trials deserve a fair reading. Still, they carry important caveats. Both studied blepharospasm, which is clinically and mechanistically distinct from the run-of-the-mill eyelid myokymia most people experience. Both were small — Garrity’s 36 participants would be considered underpowered by today’s standards for a supplement trial. And neither reconciled its positive findings with the null results produced by larger, more recent cross-sectional studies.

One plausible resolution: magnesium supplementation may help a subset of patients who are genuinely deficient, and those patients may have been overrepresented in small clinical samples. But for the average person whose eyelid twitch is triggered by a week of poor sleep and twelve-hour screen days, the serum magnesium is probably fine.

What actually seems to drive eyelid twitching

If magnesium isn’t the culprit in most cases, the data point to two variables that are much more tightly linked: fatigue and screen time.

In the Kim 2021 study, 84.9 percent of myokymia patients reported significant fatigue, compared to 69.9 percent of controls — a difference that was statistically significant (p=0.016). Sleep quality followed the same pattern; myokymia patients reported consistently worse scores. And in Gunes 2024, the nearly two-hour gap in daily screen time between the twitching group and controls was the standout finding.

This aligns with what clinicians already observe. Eyelid myokymia is classically associated with stress, sleep deprivation, caffeine excess, and prolonged near-work — the exact cluster of variables that define modern knowledge-worker life. Most ophthalmologists recommend reducing screen time, improving sleep hygiene, and cutting back on caffeine as first-line interventions. They usually work without any supplementation at all.

When magnesium might still make sense

None of this means magnesium is useless. Magnesium deficiency is real, and it’s not rare — dietary surveys consistently show that a substantial fraction of adults in Western countries consume less than recommended. The 2023 Neurology Clinical Practice review makes clear that severe hypomagnesemia can produce genuine neuromuscular symptoms, including muscle cramps and fasciculations.

If someone has a twitching eyelid and other signs that could point toward low magnesium — frequent muscle cramps, poor sleep, high stress, a diet low in leafy greens and nuts — it is not unreasonable to discuss testing or supplementation with a doctor. The serum magnesium test is inexpensive and widely available, though it has a noted limitation: because most of the body’s magnesium is stored in bone and soft tissue, a normal serum level does not perfectly rule out a functional deficiency. Some clinicians prefer red blood cell magnesium testing for a more accurate tissue-level picture, though this remains a point of debate.

If supplementation is pursued, the forms with the best bioavailability are magnesium glycinate and magnesium citrate. Magnesium oxide — the cheapest and most common form on drugstore shelves — is poorly absorbed and more likely to cause gastrointestinal side effects. Typical supplemental doses range from 200 to 400 mg of elemental magnesium per day. As with any supplement, the decision to start should be made with a healthcare provider, especially for anyone taking medications that interact with magnesium absorption or excretion.

The bottom line

The science on magnesium and eye twitching tells a clearer story than most supplement marketing lets on. Three cross-sectional studies published since 2020 — together covering more than 500 participants — failed to find any relationship between serum magnesium levels and eyelid myokymia or blepharospasm. Two older, smaller RCTs reported benefit from magnesium in blepharospasm specifically, but their findings have not been replicated in larger samples using the more common myokymia endpoint. Meanwhile, fatigue and screen time show a consistent, statistically significant association with eyelid twitching across multiple studies — which makes them the higher-yield targets for anyone trying to stop the flicker.

If your eyelid has been twitching and you’re sleep-deprived, staring at screens for seven-plus hours a day, and running on caffeine, the evidence suggests that magnesium is unlikely to be the missing piece. Fixing the sleep, stepping away from the screen, and cutting the afternoon espresso will probably do more — and those interventions come with a body of evidence that magnesium for this particular symptom simply doesn’t have yet.

References

1. Serefoglu Cabuk K, Ulas B, Yildirim Y, et al. Serum calcium, magnesium, phosphorus, and vitamin D in benign essential blepharospasm. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2020. https://link.springer.com/article/10.1007/s00417-020-04650-7
2. Kim MK, Sunwoo MK, Lee JH, et al. Will hypomagnesemia induce benign eyelid myokymia? Korean Journal of Health Promotion. 2021. https://synapse.koreamed.org/articles/1148507
3. Gunes A, Karali E, Ural A, et al. Association between eyelid twitching and digital screen time and electrolyte levels. Cureus. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11398718/
4. Eyelid myokymia. StatPearls [Internet]. NCBI Bookshelf. 2023. https://www.ncbi.nlm.nih.gov/books/NBK560595/
5. Sondhi V, Sharma S. Movement disorders associated with hypomagnesemia. Neurology Clinical Practice. 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10547470/